Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTK | P33981 | 1/20 | 0.30 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.30 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.30 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4324158 | 0.92 | TTK (0.35) | TTKMAPK8MAPK9MAPK10 | |
| SCHEMBL1385817 | 0.68 | — | — | |
| SCHEMBL23431208 | 0.68 | — | — | |
| SCHEMBL24286041 | 0.67 | ALOX5 (0.30) | — | |
| SCHEMBL24541282 | 0.67 | BCHE (0.31) | — | |
| SCHEMBL7905020 | 0.64 | MAPT (0.31) | — | |
| SCHEMBL23253993 | 0.61 | — | — | |
| SCHEMBL6410680 | 0.59 | KDM4E (0.32) | — | |
| SCHEMBL12199688 | 0.59 | ALOX5 (0.43) | — | |
| SCHEMBL16465580 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026042047-A1 | COMPOSITIONS AND ARTICLES COMPRISING REVERSIBLE COMPLEXES OF CROSSLINKED CARRAGEENAN | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| EP-2727919-B1 | BENZOCYCLOHEPTANETHIOPHENE DERIVATIVES FOR ANTI-ALLERGIC REACTIONS | FUJIAN MINDONG REJUVENATION PHARMACEUTICAL CO LTD (CN) | 2019-05-08 | — | — | EP | claimed |
| US-10022362-B2 | Anti-allergy benzocycloheptathiophene derivatives | FUJIAN MINDONG REJUVENATION PHARMACEUTICAL CO., LTD (CN) | 2018-07-17 | — | — | US | claimed |
| US-20160166563-A1 | Anti-Allergy Benzocycloheptathiophene Derivatives | FUJIAN MINDONG REJUVENATION PHARMACEUTICAL CO., LTD (CN) | 2016-06-16 | — | — | US | claimed |
| US-9296731-B2 | Anti-allergy benzocycloheptathiophene derivatives | FUJIAN MINDONG REJUVENATION PHARMACEUTICAL CO., LTD. (CN) | 2016-03-29 | — | — | US | claimed |
| US-20140135361-A1 | ANTI-ALLERGY BENZOCYCLOHEPTATHIOPHENE DERIVATIVES | FUJIAN MINDONG REJUVENATION PHARMACEUTICAL CO., LTD. (CN) | 2014-05-15 | — | — | US | claimed |
| EP-2727919-A1 | BENZOCYCLOHEPTANETHIOPHENE DERIVATIVES FOR ANTI-ALLERGIC REACTIONS | Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. (CN) | 2014-05-07 | — | — | EP | claimed |
| US-5457099-A | Carbostyril derivatives and antiallergic agent | SAWAI PHARMACEUTICAL CO., LTD. (JP) | 1995-10-10 | — | — | US | claimed |
| US-4128549-A | Precursors of 4-(1-alkyl-4-piperidylidene-4H-benzo[4,5]cyclohepta-[1,2-b]thiophen-10(9H)-ones | SANDOZ LTD. (CH) | 1978-12-05 | — | — | US | claimed |
| US-3960894-A | 9-Bromo-or chloro-9,10-dihydro-10-dihydro-10-alkoxy-4H-benzo[4,5]cyclo-hepta[1,2-b]thiophen-4-ones | SANDOZ LTD. (CH) | 1976-06-01 | — | — | US | claimed |
| WO-2026042047-A1 | COMPOSITIONS AND ARTICLES COMPRISING REVERSIBLE COMPLEXES OF CROSSLINKED CARRAGEENAN | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2026-02-26 | — | — | WO | disclosed |
| WO-2026042049-A1 | DOUBLE NETWORK HYDROGEL AND PREPARATION AND APPLICATION THEREOF | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2026-02-26 | — | — | WO | disclosed |
| US-20250288591-A1 | TRIMEPRAZINE FOR USE IN TREATING TRIGEMINAL NEURALGIA AND FOR REDUCING PAIN RELATED THERETO | UNDAUNTED BIO, INC. (US) | 2025-09-18 | — | — | US | disclosed |
| US-20250134903-A1 | COMPOSITIONS AND METHODS FOR TREATING PAIN | UNDAUNTED BIO, INC. (US) | 2025-05-01 | — | — | US | disclosed |
| EP-3927428-B1 | NORKETOTIFEN FOR USE IN THE TREATMENT OF RESPIRATORY DISORDERS | BRIDGE PHARMA INC (US) | 2025-03-05 | — | — | EP | disclosed |
| US-4031225-A | ANTIARRHYTHMIA AGENTS | SANDOZ LTD. (CH) | 1977-06-21 | — | — | US | disclosed |
| US-4024266-A | LUTEINIZING HORMONE INHIBITORS, ANTIDEPRESSANTS | SANDOZ LTD. (CH) | 1977-05-17 | — | — | US | disclosed |
| US-3960894-A | 9-Bromo-or chloro-9,10-dihydro-10-dihydro-10-alkoxy-4H-benzo[4,5]cyclo-hepta[1,2-b]thiophen-4-ones | SANDOZ LTD. (CH) | 1976-06-01 | — | — | US | disclosed |
| US-3960894-A | 9-Bromo-or chloro-9,10-dihydro-10-dihydro-10-alkoxy-4H-benzo[4,5]cyclo-hepta[1,2-b]thiophen-4-ones | SANDOZ LTD. (CH) | 1976-06-01 | — | — | US | disclosed |
| US-3862156-A | 4H-BENZO{8 4,5{9 CYCLOHEPTA{8 1,2-6{9 THIOPHENES | SANDOZ AG | 1975-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160166563-A1 | Anti-Allergy Benzocycloheptathiophene Derivatives | NR1H4, TST, CYP7A1 | TTK 3958/4885MAPK8 2662/4885MAPK9 2400/4885 |
| US-20140135361-A1 | ANTI-ALLERGY BENZOCYCLOHEPTATHIOPHENE DERIVATIVES | TST, HRH1, ABCB11 | TTK 3667/4885MAPK8 3418/4885MAPK9 2084/4885 |
| US-10022362-B2 | Anti-allergy benzocycloheptathiophene derivatives | NR1H4, TST, CYP7A1 | TTK 3958/4885MAPK8 2662/4885MAPK9 2400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.